Epoetin alfa biosimilar - Amega BitoechAlternative Names: Recombinant erythropoietin - Amega Biotech
Latest Information Update: 19 Aug 2013
At a glance
- Originator Amega Biotech
- Class Antianaemics; Recombinant erythropoietins
- Mechanism of Action Erythropoietin receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase Unknown Anaemia
Most Recent Events
- 19 Aug 2013 Investigation in Anaemia in Argentina (Parenteral)